أعرض في EDS

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration

التفاصيل البيبلوغرافية
العنوان:	The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
المؤلفون:	Villines, Todd C., Stanek, Eric J., Devine, Patrick J., Turco, Mark, Miller, Michael, Weissman, Neil J., Griffen, Len, Taylor, Allen J.
المصدر:	Journal of the American College of Cardiology. (24):2721-2726
بيانات النشر:	American College of Cardiology Foundation. Published by Elsevier Inc.
مصطلحات موضوعية:	lipids, cardiovascular system, risk factors, cardiovascular diseases, atherosclerosis
الوصف:	ObjectivesThis report describes the final results of the ARBITER 6-HALTS (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis) trial.BackgroundThe ARBITER 6-HALTS trial was terminated early on the basis of a pre-specified interim analysis showing superiority of niacin over ezetimibe on change in carotid intima-media thickness (CIMT). After termination, an additional 107 subjects completed a close-out assessment.MethodsPatients with coronary heart disease (CHD) or CHD equivalent with low-density lipoprotein cholesterol
اللغة:	English
تدمد:	0735-1097
DOI:	10.1016/j.jacc.2010.03.017
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::0a5940b11d050f6a1d4024a6ad740e7dTest
حقوق:	OPEN
رقم الانضمام:	edsair.core.ac.uk....0a5940b11d050f6a1d4024a6ad740e7d
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	07351097
DOI:	10.1016/j.jacc.2010.03.017